GlucaGen HypoKit

DRUG2 trials

Sponsors

Steno Diabetes Center Copenhagen, Zealand Pharma

Conditions

HypoglycemiaType 1 Diabetes Mellitus

Phase 3

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

CompletedNCT03667053

Zealand PharmaHypoglycemia

Start: 2018-09-28End: 2019-06-28Updated: 2021-06-30

Phase 4

The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes

Not yet recruitingCTIS2025-523996-45-00

Steno Diabetes Center CopenhagenType 1 Diabetes Mellitus

Target: 18Updated: 2026-03-16